Skip to content

Premedication for children with Tetralogy of Fallot

A comparative evalution of varies premedication regimes on children with Tetralogy of Fallot

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008571
Enrollment
Unknown
Registered
2016-05-31
Start date
2016-06-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetralogy of Fallot

Interventions

oral dexmedetomidine:oral dexmedetomidine
oral ketamine:oral ketamine
oral dexmedetomidine mixed with ketamine:oral dexmedetomidine mixed with ketamine

Sponsors

Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients ASA physical status II to III, aged from 6 to 36 months, scheduled for elective cardiac surgery (total correction) under GA will be enrolled.

Exclusion criteria

Exclusion criteria: Children with tracheobronchial stenosis, ASA physical status IV, known allergy to DEX or KET, renal or hepatic disorders, genetic or central nervous system abnormalities were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Degree of Sedation by Sedation Score;

Secondary

MeasureTime frame
seperation score;cannulation score;heart rate;blood oxygen saturation;

Countries

China

Contacts

Public ContactSun Ying

Shanghai Children's Medical Center

yingsun821@163.com+86 13621738118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026